| Date | Title | | | 05/10/13 | A.P. Pharma Announces First Quarter 2013 Financial Results and Highlights Recent Corporate Progress| REDWOOD CITY, Calif.--(BUSINESS WIRE)--May. 10, 2013-- A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today reported financial results for first quarter ended March 31, 2013 and highlighted recent corporate progress.
Financial Results and Operational Highlights
On May 2, 2013, the Company announced that the A.P. Pharma Board of Directors had appointed a new management team to lead the Company. This team includes Barry D. Quart, Pharm.D., who joined the Company as Chi... |
|  | | 05/02/13 | A.P. Pharma Appoints New Management Team| - Barry D. Quart, Pharm.D. Appointed Chief Executive Officer -
- Robert Rosen Appointed President -
- Steve Davis Appointed Chief Operating Officer -
REDWOOD CITY, Calif.--(BUSINESS WIRE)--May. 2, 2013-- A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company, today announced that its Board of Directors has appointed a new management team to lead the Company. Effective today, Barry D. Quart, Pharm.D. will join the Company as Chief Executive Officer, Robert Rosen, who joined ... |
| | | 03/28/13 | A.P. Pharma Receives FDA Complete Response Letter for APF530| - Company Revises Projected Launch Timing from 2H 2013 to 1H 2014 -
- Conference Call to Be Held at 8:30 a.m. Eastern Time -
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Mar. 28, 2013--
A.P. Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company,
today announced that it has received a Complete Response Letter (CRL)
from the U.S. Food and Drug Administration (FDA) regarding its New Drug
Application (NDA) for its lead product candi... |
| | | 03/01/13 | A.P. Pharma Announces Fourth Quarter and Full Year 2012 Financial Results and Highlights Recent Corporate Progress| REDWOOD CITY, Calif.--(BUSINESS WIRE)--Mar. 1, 2013--
A.P.
Pharma, Inc. (OTCBB: APPA.OB), a specialty pharmaceutical company,
today reported fourth quarter and full year 2012 financial results and
highlighted recent corporate progress.
“We achieved several critical objectives in 2012, highlighted by the
resubmission of our New Drug Application for APF530 to FDA in September.
Additionally, we have made a number of key appointments to th... |
| | | 02/28/13 | A.P. Pharma Appoints Jesse Hollingsworth as Vice President of Sales| REDWOOD CITY, Calif.--(BUSINESS WIRE)--Feb. 28, 2013-- A.P. Pharma, Inc. (OTCBB: APPA) today announced the appointment of Jesse Hollingsworth as vice president of sales.
“Jesse brings over a decade of highly relevant oncology sales experience, including a significant amount of knowledge working with group purchasing organizations,” said Robert Rosen, A.P. Pharma’s chief commercial officer. “Over the past several months, A.P. Pharma has been focused on recruiting key additions to our management... |
| |
|
